NEW YORK (GenomeWeb) – WaveSense, a company developing a platform for rare cell isolation and enrichment, said today that it has received CE-IVD marking for its technologies.

The approval includes the company's EpiSep direct-to-slide cell enrichment technology, as well as its proprietary paramagnetic bead technology, which allows for selective isolation of cells that express CD138.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.